Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey
dc.contributor.author | Sendur, M. A. N. | |
dc.contributor.author | Cakar, B. | |
dc.contributor.author | Hizal, M. | |
dc.contributor.author | Eraslan, E. | |
dc.contributor.author | Aksoy, S. | |
dc.contributor.author | Paydas, S. | |
dc.contributor.author | Demir, N. | |
dc.contributor.author | Sen, F. | |
dc.contributor.author | Bulut, G. | |
dc.contributor.author | Oruc, K. | |
dc.contributor.author | Uluc, B. Oyan | |
dc.contributor.author | Ozdemir, N. | |
dc.contributor.author | Sakin, A. | |
dc.contributor.author | Erdem, D. | |
dc.contributor.author | Ozkan, M. | |
dc.contributor.author | Disel, U. | |
dc.contributor.author | Ekinci, F. | |
dc.contributor.author | Okten, I. N. | |
dc.contributor.author | Ozer, L. | |
dc.contributor.author | Gokmen, E. | |
dc.date.accessioned | 2023-02-21T12:42:07Z | |
dc.date.available | 2023-02-21T12:42:07Z | |
dc.date.issued | 2021-01-01 | |
dc.description.issue | 2 | |
dc.description.issue | MAY | |
dc.description.pages | S74 | |
dc.description.volume | 32 | |
dc.identifier.doi | 10.1016/j.annonc.2021.03.138 | |
dc.identifier.uri | https://hdl.handle.net/11443/2786 | |
dc.identifier.uri | http://dx.doi.org/10.1016/j.annonc.2021.03.138 | |
dc.identifier.wos | WOS:000648924400128 | |
dc.publisher | ELSEVIER | |
dc.relation.ispartof | ANNALS OF ONCOLOGY | |
dc.title | Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey | |
dc.type | Article |